Falsified Medicines Directive: Are We Heading in the Right Direction? [PDF]
Medicine Access @ Point of Care, 2017 Falsified medicines for human use are an increasing problem in Europe. The Falsified Medicines Directive (FMD) 2011/62/EU provides measures to prevent the entry of falsified medicines into the legal supply chain by requiring the placing of safety ...
Roberto Frontini
doaj +6 more sources
Responding to the pandemic of falsified medicines. [PDF]
Am J Trop Med Hyg, 2015 Over the past decade, the number of countries reporting falsified (fake, spurious/falsely labeled/counterfeit) medicines and the types and quantities of fraudulent drugs being distributed have increased greatly. The obstacles in combating falsified pharmaceuticals include 1) lack of consensus on definitions, 2) paucity of reliable and scalable ...
Nayyar GML +8 more
europepmc +8 more sources
The EU Falsified Medicines Directive: Key Implications for Dispensers [PDF]
Medicine Access Point of Care, 2017 The EU Falsified Medicines Directive (FMD) mandates the serialisation of prescription-only medicines using a two-dimensional (2D) barcode by pharmaceutical companies and the systematic verification of this 2D barcode in pharmacies. This European directive has ramifications for many stakeholders, including market authorization holders, wholesalers ...
Bernard Naughton
exaly +7 more sources
Global perspective of the risks of falsified and counterfeit medicines: A critical review of the literature [PDF]
Travel Medicine and Infectious DiseaseBackground: The increasing prevalence of falsified and counterfeit medicines globally poses risks to international travellers. This narrative literature review examines the global challenge of falsified and counterfeit medicines, with a specific focus on
, Gérard Flaherty
exaly +5 more sources
Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries [PDF]
Frontiers in Pharmacology, 2018 Substandard and falsified (SF) medicines have emerged as a global public health issue within the last two decades especially in low- and middle-income countries (LMICs). Serious consequences of this problem include a loss of trust and increased financial
Huma Rasheed +3 more
doaj +6 more sources
Discrimination of Falsified Erectile Dysfunction Medicines by Use of an Ultra-Compact Raman Scattering Spectrometer [PDF]
Pharmacy, 2020 Substandard and falsified medicines are often reported worldwide. An accurate and rapid detection method for falsified medicines is needed to prevent human health hazards. Raman scattering spectroscopy has emerged as a non-destructive analysis method for
Tomoko Sanada +3 more
doaj +2 more sources
Development and initial validation of a postal survey evaluation of community pharmacists’ opinion regarding falsified (counterfeit) medicines in Hampshire (UK) [PDF]
Journal of Pharmacy & Pharmacognosy Research, 2018 Context: Falsified-medicines pose a worldwide problem to patients, healthcare professionals, pharmaceutical companies, and governments. Community pharmacists are usually the last points of contact with patients and can protect them by quarantining ...
Ravina Barrett, Hussein A. Al-Mousawi
doaj +6 more sources
Falsified and substandard medicines trafficking: A wakeup call for the African continent
Public Health in Practice, 2022 While great effort is being placed on reducing disease burdens in Africa, the circulation of falsified and substandard medicines in the continent are reversing the hard-won gains.
Yusuf Hassan Wada
exaly +3 more sources
What's in a Word? Falsified/Counterfeit/Fake Medicines - The Definitions Debate [PDF]
Medicine Access @ Point of Care, 2017 There is a rising tide of criminal activity to manufacture and distribute falsified, counterfeit, or fake medicines. The exact size of this problem is unknown but estimates vary from US$75 billion to US$200 billion per year, and evidence clearly ...
Mike Isles
doaj +4 more sources
Assessing knowledge, attitudes, and practices and demand-side interventions for combating substandard and falsified medicines: a scoping review [PDF]
Journal of Pharmaceutical Policy and PracticeBackground The proliferation of substandard and falsified medical products (SFM) poses a significant threat to public health globally. Despite rigorous surveillance and law enforcement efforts, risk of exposure to SFM is on the rise, notably through ...
Eishita Pal +8 more
doaj +2 more sources